Abstract | OBJECTIVE: To investigate the antiviral effect of two components (B and C) in the alcohol extracts from Loranthus yadoriki Sieb for development of new antiviral drugs for coxsackie B3 virus(CVB3). METHOD: Using ribavirin as positive control, the plaque reduction assay was adopted for pharmadynamic detection. RESULTS: In the HEp-2 cell system, with respect to direct virucidal activity and the inhibition on CVB3 infection and multiplication, ED50s of component B were 2.32 micrograms.ml-1, 0.24 microgram.ml-1 and 1.91 micrograms.ml-1, respectively and those of component C, 1.44 micrograms.ml-1, 2.06 micrograms.ml-1 and 3.70 micrograms.ml-1 respectively. For the inhibition on multiplication of CVB3, ED50 of ribavirin was 7.55 micrograms.ml-1. CONCLUSION: Treatment indexes (TI) of the direct virucidal activity and inhibitory effects of component B on CVB3 infection and multiplication 22.6, 219 and 27.5 respectively; component C, 115, 165 and 21.6; inhibition of ribavirin on CVB3 is 38, which is comparable to those of components B and C. It is thus suggested that the anti-CVB3 action of components B and C in the alcohol extracts from Loranthus yadoriki Sieb deserves to be exploited.
|
Authors | Z J Wang, Z Q Yang, T N Huang, L Wen, Y W Liu |
Journal | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
(Zhongguo Zhong Yao Za Zhi)
Vol. 25
Issue 11
Pg. 685-7
(Nov 2000)
ISSN: 1001-5302 [Print] China |
PMID | 12525075
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Antiviral Agents
- Drugs, Chinese Herbal
|
Topics |
- Antiviral Agents
(pharmacology)
- Drugs, Chinese Herbal
(isolation & purification, pharmacology)
- Enterovirus B, Human
(drug effects)
- Loranthaceae
(chemistry)
- Plants, Medicinal
(chemistry)
|